Grupo Español Multidisciplinar De Melanoma

This study is testing a two-step treatment for people with advanced melanoma that has a specific genetic change (BRAF mutation) and has spread to the brain, causing symptoms. First, patients take two targeted pills for about two months, then switch to two immunotherapy drugs give…

This study is testing whether combining two existing cancer drugs can help control advanced melanoma that has started growing again after standard immunotherapy. It will enroll 60 adults whose cancer has progressed despite prior treatment. The goal is to see if this combination c…

This study is testing a drug called tebentafusp in patients with a rare eye cancer (uveal melanoma) that has spread only to the liver. The goal is to see if giving the drug for six months before surgery can completely eliminate the cancer in the liver and help keep it from coming…